Human Fibroblasts Facilitate the Generation of IPSCs-derived Mammary-like Organoids
Overview
Authors
Affiliations
Background: Breast cancer is the most common malignancy in women worldwide, and its treatment largely depends on mastectomy. Patients after mastectomy suffer from crippled body image, self-esteem, and quality of life. Post-mastectomy breast reconstruction can improve patients' psychosocial health. Although silicone and fat have been widely used for breast reconstruction, they have remarkable limitations. Our study aimed to establish an improved method for breast reconstruction from human-induced pluripotent stem cells (iPSCs).
Methods: We used a two-step procedure to induce mammary-like organoids (MLOs) from iPSCs and applied transcriptome sequencing to analyze the gene expression profiles during the development process from embryoid bodies (mEBs) to MLOs. Moreover, we evaluated the in vitro effect of fibroblasts cell line HFF (human foreskin fibroblasts) on the size and morphology of MLOs and explored the in vivo effect of HFF on regeneration rate of MLOs.
Results: MLOs had a similar gene expression profile and morphogenesis as the normal mammary glands. Furthermore, the addition of HFF increases the branching ratio and organoid diameters and facilitates the formation of multiple cell layers duct-like structures in MLOs in vitro. Finally, orthotopical transplantation of the MLOs to cleared mammary gland fad pad of NSG mice showed that HFF increases the formation of mammary gland-like structures.
Conclusions: Fibroblasts facilitate iPSC-derived MLOs to generate mammary gland-like structures in both in vitro and in vivo conditions. Our findings lay a foundation for breast reconstruction by using iPSCs.
Yao Q, Cheng S, Pan Q, Yu J, Cao G, Li L MedComm (2020). 2024; 5(10):e735.
PMID: 39309690 PMC: 11416091. DOI: 10.1002/mco2.735.
Using Organoids to Tap Mammary Gland Diversity for Novel Insight.
Rauner G J Mammary Gland Biol Neoplasia. 2024; 29(1):7.
PMID: 38539019 PMC: 10972946. DOI: 10.1007/s10911-024-09559-z.
Patient-derived organoids: a promising tool for breast cancer research.
Shi Y, Guan Z, Cai G, Nie Y, Zhang C, Luo W Front Oncol. 2024; 14:1350935.
PMID: 38344206 PMC: 10853415. DOI: 10.3389/fonc.2024.1350935.
Sahu S, Sahoo S, Sullivan T, OSullivan T, Turan S, Albaugh M Dev Cell. 2023; 59(2):175-186.e8.
PMID: 38159568 PMC: 10872289. DOI: 10.1016/j.devcel.2023.12.003.
Chemical Evaluation, and Anticancer Activity of Grown in Jordan.
Aboalhaija N, Syaj H, Afifi F, Sunoqrot S, Al-Shalabi E, Talib W Molecules. 2022; 27(18).
PMID: 36144646 PMC: 9505037. DOI: 10.3390/molecules27185910.